Breaking News

You are here » Indian-Commodity  :  Commodities  :  Rubber  :  Physical Rubber prices witness weakness on Monday

06-Sep2016

Physical Rubber prices witness weakness on Monday

Physical rubber prices showed some weakness on Monday, as major consuming industries continued to remain on sideline. Spot prices for RSS-4 variety remained unchanged at Rs 126/ kg; while the RSS-5 variety dropped to Rs 118/ kg compared to its previous closing of Rs 119/ kg.

In the futures market, contract of September delivery improved to Rs 126.94 compared to its previous closing of Rs 125.86, while October delivery closed at Rs 116.93 compared to its previous close of Rs 115.75 on the National Multi Commodity Exchange (NMCE).


Related News

View all news

Physical Rubber prices witness some improvement on Wednesday

Physical Rubber prices showed some improvement on Wednesday. Spot prices for RSS-4 variety remained unchanged at Rs 127.50/ kg; while the RSS-5 variety jumped to 123/ kg compared to its previous closing......

Physical Rubber prices witness some improvement on Wednesday

Physical Rubber prices showed some improvement on Wednesday. Spot prices for RSS-4 variety remained unchanged at Rs 127.50/ kg; while the RSS-5 variety jumped to 123/ kg compared to its previous closing......

Physical Rubber prices witness weakness on Monday

Physical Rubber prices showed weakness on Monday. Spot prices for RSS-4 variety fell to Rs 127.50/ kg compared to its previous closing of Rs 128/ kg; while the RSS-5 variety declined to Rs 122.50/ kg compared......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......